Related Experiment Video
Updated: Jun 14, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Clostridioides difficile toxin testing and positivity in Manitoba, Canada
Christiaan H Righolt1, Geng Zhang1, Gregory W Hammond2
1Vaccine and Drug Evaluation Centre, Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Abstract:
We assessed Clostridioides difficile toxin testing and positivity for all patients in Manitoba hospitals during June 2016-November 2018. The testing rate was 30 per 10,000 patient bed days (95% confidence interval [CI], 30-31) and the incidence rate was 3.5 per 10,000 patient bed days (95% CI, 3.3-3.7). The context of testing is essential to the interpretation of data among jurisdictions.
More Related Videos
12:58A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
09:12A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
Related Concept Videos
Rapid Identification of Pathogens
Automated Microbial Diagnostics
Diphtheria